Dachaigh › Leukemia
Sgrùdaidhean clionaigeach Leukemia a’ fastadh anns na SA
Tha 102 sgrùdaidhean airson Leukemia a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX28 sgrùdaidhean
- Boston, MA25 sgrùdaidhean
- New York City, NY19 sgrùdaidhean
- Los Angeles, CA16 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
- Durham, NC13 sgrùdaidhean
- Baldwin Park, CA12 sgrùdaidhean
- Nashville, TN12 sgrùdaidhean
- Columbus, OH12 sgrùdaidhean
- Philadelphia, PA12 sgrùdaidhean
- Milwaukee, WI11 sgrùdadh
- Atlanta, GA11 sgrùdadh
- Seattle, WA11 sgrùdadh
- Birmingham, AL10 sgrùdaidhean
- Aurora, CO10 sgrùdaidhean
- Edison, NJ9 sgrùdaidhean
- Mountain View, CA9 sgrùdaidhean
- Miami, FL9 sgrùdaidhean
- Cincinnati, OH9 sgrùdaidhean
- Portland, OR8 sgrùdaidhean
- Dallas, TX8 sgrùdaidhean
- Queens, NY8 sgrùdaidhean
- New Haven, CT8 sgrùdaidhean
- Buffalo, NY7 sgrùdaidhean
- Denver, CO7 sgrùdaidhean
- Washington, DC7 sgrùdaidhean
- Tampa, FL7 sgrùdaidhean
- Orange, CA7 sgrùdaidhean
- Clifton, NJ7 sgrùdaidhean
- Cedar Rapids, IA6 sgrùdaidhean
- Omaha, NE6 sgrùdaidhean
- Charlottesville, VA5 sgrùdaidhean
- Ann Arbor, MI5 sgrùdaidhean
- Baltimore, MD5 sgrùdaidhean
- Memphis, TN5 sgrùdaidhean
- Rochester, MN5 sgrùdaidhean
- San Diego, CA5 sgrùdaidhean
- Cleveland, OH5 sgrùdaidhean
- Charlotte, NC5 sgrùdaidhean
- Rochester, NY4 sgrùdaidhean
Le stàit
- Alabama10 sgrùdaidhean
- Arizona7 sgrùdaidhean
- California28 sgrùdaidhean
- Colorado15 sgrùdaidhean
- Connecticut11 sgrùdadh
- Florida17 sgrùdaidhean
- Georgia13 sgrùdaidhean
- Illinois17 sgrùdaidhean
- Indiana4 sgrùdaidhean
- Iowa7 sgrùdaidhean
- Kansas5 sgrùdaidhean
- Kentucky6 sgrùdaidhean
- Louisiana3 sgrùdaidhean
- Maine3 sgrùdaidhean
- Maryland11 sgrùdadh
- Massachusetts28 sgrùdaidhean
- Michigan8 sgrùdaidhean
- Minnesota9 sgrùdaidhean
- Missouri6 sgrùdaidhean
- Nebraska6 sgrùdaidhean
- New Jersey15 sgrùdaidhean
- New Mexico3 sgrùdaidhean
- New York26 sgrùdaidhean
- North Carolina20 sgrùdaidhean
- Ohio26 sgrùdaidhean
- Oklahoma4 sgrùdaidhean
- Oregon9 sgrùdaidhean
- Pennsylvania15 sgrùdaidhean
- Rhode Island4 sgrùdaidhean
- South Carolina6 sgrùdaidhean
- Tennessee14 sgrùdaidhean
- Texas31 sgrùdaidhean
- Utah4 sgrùdaidhean
- Vermont4 sgrùdaidhean
- Virginia7 sgrùdaidhean
- Washington11 sgrùdadh
- Wisconsin13 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Rutgers University Study of the Genetics of Blood Cancers
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00923507Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
A’ fastadhÌre 3
Aoisean 18 gu 71 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07504458Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
A’ fastadhÌre 2
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05645718Natural History Study of GATA2 Deficiency and Related Disorders
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 100 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT01905826A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
A’ fastadhÌre 1/2
30 Days · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04065399Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
A’ fastadhÌre 1
Suas gu aois 75 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06345027Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06824168A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
A’ fastadhÌre 1
Suas gu aois 25 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06810583(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04996875A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06229912Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06907797Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
A’ fastadhÌre 3
Aoisean 18 gu 18 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07509151Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07249346Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07354074Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
A’ fastadhÌre 1
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07586618Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 5 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT05237986CIML NK Cells With Venetoclax for AML
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06152809Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07284433Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07439211Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
A’ fastadhÌre 1
18 Months – 39 Years · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT07573111Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.